ArticleCancer research2018

Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine.

Siang-Boon Koh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.